ID: ALA2235245

Max Phase: Preclinical

Molecular Formula: C21H22O5

Molecular Weight: 354.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(C)C)cc3o2)cc1

Standard InChI:  InChI=1S/C21H22O5/c1-12(2)24-15-7-5-14(6-8-15)19-11-18(23)21-17(22)9-16(25-13(3)4)10-20(21)26-19/h5-13,22H,1-4H3

Standard InChI Key:  MNLRCTDHXYRFLN-UHFFFAOYSA-N

Associated Targets(non-human)

Avian myoblastosis virus polyprotein II 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 354.40Molecular Weight (Monoisotopic): 354.1467AlogP: 4.74#Rotatable Bonds: 5
Polar Surface Area: 68.90Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.36CX Basic pKa: CX LogP: 4.55CX LogD: 4.23
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: 0.51

References

1. Phosrithong N, Samee W, Ungwitayatorn J.  (2012)  3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors,  21  (5): [10.1007/s00044-011-9570-z]

Source